Serial Number
85339976
Owner
Centre for Probe Development and CommercializationAttorney
Nicole K. McLaughlinFiling Date
Jun 7, 2011
CPDC CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION Trademark
Serial Number: 85339976 • Registration: 4680431
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 40 - Treatment & Processing
Treatment of materials
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 45 - Legal & Security Services
Legal services; security services for the protection of property and individuals
Owner Contact Info
175 Longwood Rd. S.
Hamilton, Ontario L8P 0A1 , CA
Entity Type: 03
Legal Representation
Correspondence Address
Nicole K. McLaughlin DUANE MORRIS LLP
30 SOUTH 17TH STREET
PHILADELPHIA, PA 19103-4196
United States
Trademark Details
Filing Date
June 7, 2011
Registration Date
February 3, 2015
Published for Opposition
November 18, 2014
Goods & Services
[ Manufacturing of imaging probes and therapeutic agents for others ]
[ Diagnostic and therapeutic radiopharmaceutical preparations for use in evaluating the treatment of diseases]
[ Providing assistance with regulatory matters in the field of radiopharmaceuticals for regulatory compliance purposes ]
[ Imaging probes for diagnostic and medical use and molecular probes for therapeutic use ]
Research and development of radiopharmaceuticals; research and development of imaging probes; consulting services in the field of imaging probe development and the development of radiopharmaceuticals [; project management in the field of probe development and the development of radiopharmaceuticals; chemistry lab services for radiopharmaceuticals; biological lab services for radiopharmaceuticals; pre-clinical and clinical research and trials in the field of radiopharmaceuticals; microbiology lab services; biological testing in the field of radiopharmaceuticals; drug product formulation development services ]
